Decatur Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-15,121
Closed -$1.12M 56
2023
Q1
$1.12M Sell
15,121
-2,851
-16% -$239K 0.85% 47
2022
Q4
$1.68M Hold
17,972
1.21% 30
2022
Q3
$1.71M Sell
17,972
-3
-0% -$297 1.3% 26
2022
Q2
$1.67M Hold
17,975
1.23% 29
2022
Q1
$1.82M Buy
17,975
+9,081
+102% +$954K 1.06% 30
2021
Q4
$918K Sell
8,894
-102
-1% -$9.43K 0.54% 50
2021
Q3
$763K Buy
+8,996
New +$754K 0.5% 53
2013
Q4
Sell
-108,350
Closed -$6.15M 96
2013
Q3
$6.15M Buy
108,350
+23,200
+27% +$1.38M 1.3% 35
2013
Q2
$4.87M Buy
+85,150
New +$4.93M 1.69% 27

Other funds holding CVS

Decatur Capital Management's CVS Position: Q2 2023 in Review

Decatur Capital Management sold out of CVS Health (CVS) in Q2 2023, closing a stake of 15,121 shares — an estimated $1.12M sold.

Decatur Capital Management first reported a position in CVS in Q2 2013 and held it in 9 quarters. The position peaked at $6.15M in Q3 2013. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Decatur Capital Management reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
  • Decatur Capital Management sold 15,121 CVS Health shares in Q2 2023, an estimated $1.12M.
  • Decatur Capital Management first reported a position in CVS Health in Q2 2013 and held it in 9 quarters.
  • Decatur Capital Management's CVS Health position peaked at $6.15M in Q3 2013.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Decatur Capital Management's 13F filing for Q2 2023, filed 9 Aug 2023.